Back to search

Article

Discovery and Validation of COL11A1 as a Therapeutic Target for Sorafenib Resistance in Lung Adenocarcinoma

2026-02-06

Abstract excerpt

<title>Abstract</title> <p>Objective To investigate the expression characteristics, prognostic value, and role of COL11A1 in Sorafenib resistance in lung adenocarcinoma (LUAD). Methods The expression differences of COL11A1 in LUAD were analyzed based on The Cancer Genome Atlas (TCGA) database. Kaplan-Meier survival analysis was performed to evaluate prognostic value, and drug sensitivity analysis was conducted...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
39ffadee-2dd6-5f2d-a2da-55463313864e
DOI
10.21203/rs.3.rs-8546693/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Discovery and Validation of COL11A1 as a Therapeutic Target for Sorafenib Resistance in Lung AdenocarcinomaDOI 10.21203/rs.3.rs-8546693/v1
Select a neighboring publication to make it the new centre.